September 6, 2017, WINOOSKI VT, USA — BioTek proudly announces its donation of $25,000 towards the construction of the Science, Technology, Engineering and Mathematics (STEM) Complex at The University ...

Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis BioTek is a recognized leader for plate ...

BioTek Instruments, Inc., is a global leader in the development, manufacture and sale of microplate instrumentation and software. Servicing customers across the world requires rapid responses and ...

Since the onset of the current pandemic, COVID-19 has been described largely as a respiratory disease. While the respiratory tract and alveoli are one of the primary sites of infection and pathology, ...

BioTek Instruments is pleased to announce its collaboration with MilliporeSigma on an integrated solution for long-term live cell experiments and dynamic time-lapse analyses, including automated cell ...

BioTek Instruments announces enhancements to the MultiFlo™ FX Multi-Mode Dispenser to facilitate cell biology workflows. MultiFlo FX has a modular design that makes it easy for users to add ...

SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today announced it has completed the acquisition of BioTek Instruments, a global leader in the design, manufacture and ...

Click to share on Facebook (Opens in new window) Click to share on X (Opens in new window) Click to email a link to a friend (Opens in new window) Click to share on LinkedIn (Opens in new window) ...

Agilent Technologies, Inc.A and BioTek Instruments recently teamed up to develop a new integrated solution that combines cellular metabolic analysis and imaging technologies. Vermont-based, BioTek ...

Invitrogen Corporation and BioTek Instruments, Inc. have entered into a collaboration agreement to validate the compatibility of Invitrogen’s reagents and technology platforms with BioTek’s microplate ...

Agilent A will acquire BioTek Instruments in a $1.165 billion deal. The transaction is expected to be completed in Agilent’s fiscal fourth quarter. BioTek designs, manufactures and distributes life ...

Combined portfolio enables Agilent to provide a more complete and integrated solution for customers in the important and fast-growing area of live cell analysis BioTek is a recognized leader for plate ...